BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2643 related articles for article (PubMed ID: 20952254)

  • 21. Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.
    Alemany L; de Sanjosé S; Tous S; Quint W; Vallejos C; Shin HR; Bravo LE; Alonso P; Lima MA; Guimerà N; Klaustermeier J; Llombart-Bosch A; Kasamatsu E; Tatti SA; Felix A; Molina C; Velasco J; Lloveras B; Clavero O; Lerma E; Laco J; Bravo IG; Guarch R; Pelayo A; Ordi J; Andújar M; Sanchez GI; Castellsagué X; Muñoz N; Bosch FX;
    Int J Cancer; 2014 Jul; 135(1):88-95. PubMed ID: 24382655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of multiple HPV infection in cervical cancer patients and its impact on treatment response.
    Munagala R; Donà MG; Rai SN; Jenson AB; Bala N; Ghim SJ; Gupta RC
    Int J Oncol; 2009 Jan; 34(1):263-71. PubMed ID: 19082497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
    Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus type distribution in cervical cancer in Delhi, India.
    Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
    Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
    Zhao C; Li Z; Austin RM
    Am J Clin Pathol; 2013 Jul; 140(1):47-54. PubMed ID: 23765533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
    Ndiaye C; Alemany L; Ndiaye N; Kamaté B; Diop Y; Odida M; Banjo K; Tous S; Klaustermeier JE; Clavero O; Castellsagué X; Bosch FX; Trottier H; de Sanjosé S
    Trop Med Int Health; 2012 Dec; 17(12):1432-40. PubMed ID: 23107344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus and cervical cancer: failure to detect a direct association or an interaction with human papillomaviruses.
    Thompson CH; Rose BR; Elliott PM
    Gynecol Oncol; 1994 Jul; 54(1):40-6. PubMed ID: 8020838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India.
    Patel KR; Vajaria BN; Begum R; Desai A; Patel JB; Shah FD; Shukla SN; Patel PS
    J Oral Pathol Med; 2014 Apr; 43(4):293-7. PubMed ID: 24372728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.
    Pirog EC; Kleter B; Olgac S; Bobkiewicz P; Lindeman J; Quint WG; Richart RM; Isacson C
    Am J Pathol; 2000 Oct; 157(4):1055-62. PubMed ID: 11021808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia.
    Schellekens MC; Dijkman A; Aziz MF; Siregar B; Cornain S; Kolkman-Uljee S; Peters LA; Fleuren GJ
    Gynecol Oncol; 2004 Apr; 93(1):49-53. PubMed ID: 15047213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.
    Ogura K; Ishi K; Matsumoto T; Kina K; Nojima M; Suda K
    Pathol Int; 2006 Jun; 56(6):301-8. PubMed ID: 16704493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
    Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
    BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
    Walboomers JM; Jacobs MV; Manos MM; Bosch FX; Kummer JA; Shah KV; Snijders PJ; Peto J; Meijer CJ; Muñoz N
    J Pathol; 1999 Sep; 189(1):12-9. PubMed ID: 10451482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
    Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
    Int J Gynecol Cancer; 2001; 11(1):39-48. PubMed ID: 11285032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK).
    Powell N; Cuschieri K; Cubie H; Hibbitts S; Rosillon D; De Souza SC; Molijn A; Quint W; Holl K; Fiander A
    J Clin Virol; 2013 Nov; 58(3):571-4. PubMed ID: 24051043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical adenocarcinoma: moving towards better prevention.
    Seoud M; Tjalma WA; Ronsse V
    Vaccine; 2011 Nov; 29(49):9148-58. PubMed ID: 21983356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.
    Hooi DJ; Lissenberg-Witte BI; de Koning MNC; Pinedo HM; Kenter GG; Meijer CJ; Quint WG
    Sex Transm Infect; 2018 Jun; 94(4):263-267. PubMed ID: 29021405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV genotype distribution in older Danish women undergoing surgery due to cervical cancer.
    Hammer A; Mejlgaard E; Gravitt P; Høgdall E; Christiansen P; Steiniche T; Blaakaer J
    Acta Obstet Gynecol Scand; 2015 Nov; 94(11):1262-8. PubMed ID: 26300424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 133.